Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05596344

Long-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors

This study was a single-center prospective, real-world observational study with plans to enroll all eligible patients. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Malignant Tumor Anxiety Anxiety Disorders Behavior Behavioral Symptoms Depression Mental Disorders Neoplasms

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Bone and Soft Tissue ,Henan Cancer Hospital

Zhengzhou, Henan, 450008, China

Location status: Recruiting

Location contact

Tian Zhichao, Dr.

CONTACT

[email protected]

+8618737187831

About this study

A total of 200 patients with malignant tumors will be enrolled in Henan Cancer Hospital. This study is a single-center prospective real-world observational study, and all eligible patients are planned to be enrolled. The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women of all ages are welcome.
  • Pathological diagnosis of malignant tumor in our hospital.
  • Received at least one hospitalization at this hospital.
  • The expected survival time is greater than 1 year.

Exclusion criteria

1.There was no pathological report of malignancy.

Treatment and study plan

Hospital Anxiety and Depression Scale

Other

The basic information, anxiety and depression, treatment and prognosis of these patients were collected.

Primary outcomes

  1. Hospital Anxiety Depression Scale

    Time frame: Confirmed in 1 day

    Confirmed in 1 day

  2. Hospital Anxiety Depression Scale

    Time frame: End of the treatment

    End of the treatment

  3. Hospital Anxiety Depression Scale

    Time frame: The treatment ended 3 months later

    The treatment ended 3 months later

  4. Hospital Anxiety Depression Scale

    Time frame: The treatment ended 6 months later

    The treatment ended 6 months later

  5. Hospital Anxiety Depression Scale

    Time frame: The treatment ended one year later

    The treatment ended one year later

  6. Hospital Anxiety Depression Scale

    Time frame: The treatment ended 2 years ago

    The treatment ended 2 years ago

Study contacts

Contact information is provided by the study sponsor or research team.

Wang Jiaqiang, Dr

CONTACT

[email protected]

13592413731

Sponsors and collaborators

Lead sponsor

Henan Cancer Hospital

Other Gov

Registry information

Official study title

A Single-center, Real-world Prospective Observational Study of the Incidence and Development of Anxiety and Depression in Patients With Malignant Tumors

Important dates

Study start
2023
Primary completion
2032
Study completion
2032
First posted
Oct 27, 2022
Registry last updated
Nov 13, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.